

01 May 2026
// INDPHARMAPOST
https://www.indianpharmapost.com/news/merck-kgaa-launches-phase-3-push-for-lupus-skin-disease-with-enpatoran-trials-20021

30 Apr 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260429442071/en/Merck-KGaA-Darmstadt-Germany-Announces-First-Dose-in-Phase-3-Study-with-Enpatoran-for-Lupus-Patients-with-Active-Skin-Manifestations